Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Agrochemical Giants Face Explosive Paraquat Parkinson's Disease Allegations as Wisner Baum Trial Date is Set in California


News provided by

Wisner Baum

Jun 09, 2026, 09:00 ET

Share this article

Share toX

Share this article

Share toX

California's first paraquat Parkinson's trial is set for March 1, 2027, as litigation against Syngenta and Chevron progresses. The case alleges manufacturers knew or should have known about paraquat's neurotoxic properties and failed to adequately warn consumers about risks. 

LOS ANGELES, June 9, 2026 /PRNewswire/ -- Nationwide paraquat litigation moved one step closer to trial when the first California case was scheduled for March 1, 2027, in Contra Costa County Superior Court. The plaintiff alleges that exposure to the pesticide paraquat caused his Parkinson's disease. Anderson v. Syngenta AG, et al. is expected to become a landmark proceeding that will shape future litigation for thousands of other farmers and agricultural workers with Parkinson's across the country.

Continue Reading
”This trial will be a critical opportunity to give agricultural workers and their families their day in court and to demand accountability from companies that have profited from a dangerous product for decades.” - Conor Kennedy, associate attorney at Wisner Baum
”This trial will be a critical opportunity to give agricultural workers and their families their day in court and to demand accountability from companies that have profited from a dangerous product for decades.” - Conor Kennedy, associate attorney at Wisner Baum

Wisner Baum LLP, a nationally recognized plaintiffs' law firm, is representing the Anderson family alongside co-counsel R. Allen Smith Jr. of The Smith Law Firm. Attorneys Brent Wisner, Conor Kennedy and Harrison E. James will serve on the plaintiffs' trial team for the case. The firm is representing farmers, pesticide applicators, landscapers, and others who sprayed Gramoxone® and other paraquat-containing products and later developed Parkinson's disease or Parkinsonism.

"This will be the first time a California jury will hear the evidence about what paraquat manufacturers knew regarding the herbicide's connection to Parkinson's disease," said Brent Wisner, lead trial attorney and managing partner of Wisner Baum. "These cases reveal a disturbing reality: Syngenta and Chevron knew for decades that paraquat destroyed the dopamine-creating cells in the brain—the very cells that, when dead, cause Parkinson's. It's reprehensible, and when a jury sees this evidence, most of which is still sealed from public scrutiny, there will be a reckoning."

A Progressive Disease with Life-Altering Consequences

Parkinson's disease is a progressive neurological disorder that affects movement, coordination, and cognitive functioning. Symptoms include tremors, rigidity, slowed movement, balance impairment, and other debilitating complications. As the disease advances into its later stages, patients face compounding medical crises that often prove fatal.

Nearly one million Americans are currently living with the disease, according to the Parkinson's Foundation. Some studies have found increased risk among populations who live in rural areas or drink well water, findings that may ultimately be linked to pesticide runoff.

Decades of Exposure, Known Toxic Properties

Plaintiffs Keith and Cheryl Anderson allege that prolonged paraquat exposure on their California walnut farm caused Mr. Anderson to develop Parkinson's disease.

According to the complaint, Mr. Anderson was repeatedly exposed to paraquat from approximately 1994 through 2022, via mixing, loading, spraying, and otherwise handling paraquat products, including Gramoxone®.

The complaint alleges the neurotoxin entered his body through inhalation, skin absorption, and ingestion during routine agricultural use, and—as a result—Mr. Anderson developed Parkinson's disease and was diagnosed in 2021.

The lawsuit further alleges that manufacturers Syngenta and Chevron knew, or should have known, about paraquat's neurotoxic properties for decades, yet failed to adequately warn users. "Keith Anderson represents thousands of people who used these products, unaware of the risk, and now face devastating neurological injuries allegedly linked to years of exposure," James said.

Scientific Evidence Has Mounted for Years

More than a decade ago, laboratory studies found that paraquat can cause oxidative stress and damage to dopamine-producing neurons. Several other epidemiological and laboratory studies have likewise linked paraquat exposure to elevated Parkinson's disease risk.

Research from the Agricultural Health Study (AHS), a large, federally funded cohort of pesticide applicators, reported that exposure to paraquat was associated with an elevated risk of Parkinson's disease among agricultural workers.

A related, more targeted study published soon after confirmed AHS's findings. Top Parkinson's disease researchers concluded that with respect to paraquat being associated with Parkinson's disease, "[t]he data is overwhelming." A lead investigator at the National Institutes of Health described it as "about as persuasive as these things can get."

"Thanks to independent scientists, we're now aware of the danger, but the public should have known decades ago," said Kennedy. "This trial will be a critical opportunity to give agricultural workers and their families their day in court and to demand accountability from companies that have profited from a dangerous product for decades."

Scrutiny Amidst Restrictions

The case comes amid growing scrutiny over paraquat, which remains widely used in U.S. agriculture despite bans or restrictions in dozens of countries.

"When you see a chemical banned across large parts of the world but still widely used in American agriculture, you have to wonder whether the system designed to protect public health is working the way it's supposed to," Wisner said.

Plaintiffs' attorneys contend that internal corporate documents obtained through discovery may show longstanding knowledge of paraquat's toxicity and potential connection to neurological injury. "Syngenta explicitly said that its stewardship of paraquat would involve the 'placing of economics before safety,'" Kennedy said.

"For years, these issues largely remained buried in scientific literature and internal corporate records," James said. "Now, jurors will have the opportunity to evaluate the evidence that these companies acted recklessly."

About Wisner Baum 

Wisner Baum is a nationally recognized plaintiffs' law firm with offices across the United States. For decades, the firm has represented individuals harmed by corporate misconduct, dangerous products, environmental exposure, and systemic failures. Wisner Baum is known for its trial experience, investigative rigor, and leadership in complex, high-impact litigation involving some of the world's largest companies. For more information, visit www.wisnerbaum.com 

References

  • Anderson, K., & Anderson, C. (2022, August 5). Complaint for damages (Case No. C22-01622). Superior Court of the State of California, County of Contra Costa, Judicial Council Coordinated Proceeding No. 5031, California Paraquat Cases. 
  • Baltazar, M. T., Dinis-Oliveira, R. J., de Lourdes Bastos, M., Tsatsakis, A. M., Duarte, J. A., & Carvalho, F. (2014). Pesticides exposure as etiological factors of Parkinson's disease and other neurodegenerative diseases—A mechanistic approach. Toxicology Letters, 230(2), 85–103. 
  • Parkinson's Foundation. (2024). Statistics on Parkinson's disease. 
  • Tanner, C. M., Kamel, F., Ross, G. W., Hoppin, J. A., Goldman, S. M., Korell, M., Marras, C., Bhudhikanok, G. S., Kasten, M., Chade, A. R., Comyns, K., Richards, M. B., Meng, C., Priestley, B., Fernandez, H. H., Cambi, F., Umbach, D. M., Blair, A., Sandler, D. P., & Langston, J. W. (2011). Rotenone, paraquat, and Parkinson's disease. Environmental Health Perspectives, 119(6), 866–872. 

Media Contact:

Karla Jo Helms
JOTO PR
727-777-4629
jotopr.com

SOURCE Wisner Baum

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Mounting Rx Lawsuits Expose Ongoing Concerns Over FDA's Revolving Door

Mounting Rx Lawsuits Expose Ongoing Concerns Over FDA's Revolving Door

The pharmaceutical industry is no stranger to litigation. For example, more than 3,600 lawsuits involving GLP-1 drugs are currently pending in...

Wisner Baum Investigates Syngenta Amid Renewed Questions Over Atrazine Safety

Wisner Baum Investigates Syngenta Amid Renewed Questions Over Atrazine Safety

A growing body of scientific research is intensifying scrutiny of atrazine, one of the most commonly used herbicides in American agriculture, over...

More Releases From This Source

Explore

Agriculture

Agriculture

Health Care & Hospitals

Health Care & Hospitals

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.